2024-09-01 2025-08-31 false No description of principal activity Capium Accounts Production 1.1 08189740 2024-09-01 2025-08-31 08189740 bus:FullAccounts 2024-09-01 2025-08-31 08189740 bus:FRS102 2024-09-01 2025-08-31 08189740 bus:AuditExemptWithAccountantsReport 2024-09-01 2025-08-31 08189740 bus:SmallCompaniesRegimeForAccounts 2024-09-01 2025-08-31 08189740 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 08189740 2024-09-01 2025-08-31 08189740 2025-08-31 08189740 bus:RegisteredOffice 2024-09-01 2025-08-31 08189740 core:WithinOneYear 2025-08-31 08189740 core:AfterOneYear 2025-08-31 08189740 1 2024-09-01 2025-08-31 08189740 bus:Director1 2024-09-01 2025-08-31 08189740 bus:Director1 2025-08-31 08189740 bus:Director1 2023-09-01 2024-08-31 08189740 2023-09-01 08189740 bus:LeadAgentIfApplicable 2024-09-01 2025-08-31 08189740 2023-09-01 2024-08-31 08189740 2024-08-31 08189740 core:WithinOneYear 2024-08-31 08189740 core:AfterOneYear 2024-08-31 08189740 bus:EntityAccountantsOrAuditors 2023-09-01 2024-08-31 08189740 bus:OrdinaryShareClass1 2024-09-01 2025-08-31 08189740 bus:OrdinaryShareClass1 2025-08-31 08189740 bus:OrdinaryShareClass1 2023-09-01 2024-08-31 08189740 bus:OrdinaryShareClass1 2024-08-31 08189740 core:CostValuation core:Non-currentFinancialInstruments 2025-08-31 08189740 core:CostValuation core:Non-currentFinancialInstruments 2024-08-31 08189740 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-08-31 08189740 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-08-31 08189740 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-08-31 08189740 core:Non-currentFinancialInstruments 2025-08-31 08189740 core:Non-currentFinancialInstruments 2024-08-31 08189740 core:ShareCapital 2025-08-31 08189740 core:ShareCapital 2024-08-31 08189740 core:RetainedEarningsAccumulatedLosses 2025-08-31 08189740 core:RetainedEarningsAccumulatedLosses 2024-08-31 08189740 dpl:Item1 2024-09-01 08189740 dpl:Item1 2025-08-31 08189740 dpl:Item1 2023-09-01 08189740 dpl:Item1 2024-08-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 08189740
England and Wales

 

 

 


Unaudited Financial Statements


for the year ended 31 August 2025

for

GOLDEN MEDICAL LTD

 
 
Notes
 
2025
£
  2024
£
Current assets      
Debtors 3   5,773 
Cash at bank and in hand   (19)
  5,754 
Creditors: amount falling due within one year 4   (720)
Net current assets   5,034 
 
Total assets less current liabilities   5,034 
Net assets   5,034 
 

Capital and reserves
     
Called up share capital 5 100    100 
Profit and loss account (100)   4,934 
Shareholders' funds   5,034 
 


For the year ended 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the director on 12 November 2025 and were signed by:


-------------------------------
Susan Berry
Director
1
General Information
Golden Medical Ltd is a private company, limited by shares, registered in England and Wales, registration number 08189740, registration address 89 Avocet Rise, Sprowston, Norwich, Norfolk, NR7 8EU.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
2.

Average number of employees

Average number of employees during the year was 0 (2024 : 0).
3.

Debtors: amounts falling due after one year

2025
£
  2024
£
Directors' Loan Accounts   5,773 
  5,773 

4.

Creditors: amount falling due within one year

2025
£
  2024
£
Accrued Expenses   720 
  720 

5.

Creditors: amount falling due after more than one year

2025
£
  2024
£
 

6.

Share Capital

Allotted, called up and fully paid
2025
£
  2024
£
100 Class A shares of £1.00 each 100    100 
100    100 

2